Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News

Muscle Is the Longevity Asset Most People Ignore

by Team Lumida
February 26, 2026
in News
Reading Time: 3 mins read
A A
0
topless man with black background

Photo by Nigel Msipa on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key takeaways

Powered by lumidawealth.com

  • Higher muscle mass and strength are strongly associated with lower all-cause mortality.
  • Muscle improves glucose control, insulin sensitivity, and metabolic flexibility.
  • Age-related muscle loss (sarcopenia) accelerates frailty, falls, and chronic disease risk.
  • Resistance training and adequate protein intake are among the most effective longevity interventions.

What Happened?

Longevity science increasingly highlights skeletal muscle as more than a mobility tissue—it functions as a metabolic organ. Research shows that individuals with greater grip strength and lean muscle mass have significantly lower risks of cardiovascular disease, type 2 diabetes, and premature death. At the same time, age-related muscle decline begins as early as the 30s and accelerates after 60, reducing functional capacity and increasing vulnerability to illness and injury.

Why It Matters?

Muscle directly regulates glucose disposal and insulin sensitivity, acting as a large reservoir for circulating sugar. More muscle means better metabolic stability, lower inflammatory burden, and greater resilience during acute stressors such as infections or hospitalization. In aging populations, preserving muscle mass reduces fall risk, supports independence, and lowers healthcare utilization. From a cost-benefit perspective, resistance training offers one of the highest returns per hour invested compared with many medical interventions.

What’s Next?

Expect greater integration of strength metrics—such as grip strength and lean mass scans—into preventive health frameworks. Watch for growing emphasis on protein optimization (especially in older adults), structured resistance training, and metabolic monitoring as mainstream longevity strategies. The long-term opportunity lies in shifting from reactive healthcare to proactive muscle preservation as a foundational pillar of healthy aging.

Previous Post

Tariff Volatility Accelerates Africa’s Shift Away From the Dollar, Ecobank Warns

Next Post

Paramount Wins Warner Discovery After Netflix Walks—A $81B Media Megamerger Takes Shape

Recommended For You

Iran Is Building a ‘Survival Economy’ to Outlast Trump’s Sanctions and Naval Blockade — Rationing, FX Controls, and Household Sacrifice to Keep the State Running

by Team Lumida
2 hours ago
Iran Is Running the 1980s Tanker War Playbook Again — This Time With Drones

Tehran is deliberately engineering lower living standards to preserve the state, absorbing sanctions and a US naval blockade rather than negotiating.

Read more

Bank of America to Deploy $250 Billion Into AI and Energy Infrastructure — Data Centers, Critical Minerals, and Wall Street’s Race to Finance America’s Power Build-Out

by Team Lumida
2 hours ago
a bank of america logo on a white dice

BofA's $250B commitment — spanning lending, investing, underwriting, and advisory — positions it as a lead financier of the AI-driven infrastructure supercycle.

Read more

Bessent vs. Takaichi: The US-Japan Policy Divide That Could Determine When the BOJ Hikes Next

by Team Lumida
2 hours ago
US Treasury Secretary Bessent: Terming Out US Debt Is “A Long Way Off”

Bessent wants the BOJ to hike now; Takaichi fears repeating the 2006 mistake. The yen is sliding back toward 160 and markets are watching September.

Read more

World Cup Is Over and So Is the Prediction Market Hype Cycle — Polymarket Volume Craters 56%, Kalshi Gains Ground as the Two Giants Diverge

by Team Lumida
2 hours ago
Prediction Markets Are Going Full Crypto — Kalshi and Polymarket Both Launching Leveraged Perpetual Futures

Post-World Cup volume collapse exposes prediction markets' event dependency. Polymarket down 56%, Kalshi down 25% — and the two platforms are on very different trajectories.

Read more

NYC Opens Investigation Into Polymarket, Kalshi, Coinbase, and Gemini — Deceptive Marketing and Targeting Minors Alleged in New Legal Front Against Crypto and Prediction Markets

by Team Lumida
2 hours ago
landscape photo of New York Empire State Building

New York City Council Speaker Julie Menin sent investigative letters to four crypto and prediction market firms on Aug 11, alleging deceptive marketing and targeting of minors.

Read more

Paramount Could Leave California as Soon as October Over $81 Billion Warner Bros. Antitrust Fight — 12 States Are Suing to Block the Deal

by Team Lumida
2 hours ago
a blue container with a logo

Paramount executives say a California exit is "on the table" if the antitrust lawsuit blocking its Warner Bros. Discovery acquisition can't be resolved — a move that could...

Read more

Anthropic’s $965 Billion IPO Roadshow Faces Hard Questions on Chinese AI, Trump Tensions, and Data Center Backlash

by Team Lumida
1 day ago
Pentagon–Anthropic Feud Escalates as AI Policy Clash Threatens Defense Contracts

Anthropic is meeting with investors ahead of what could be the largest IPO in history, addressing growing skepticism about the threat from cheaper Chinese AI models, friction with...

Read more

Fed’s Warsh Faces First Real Test: Two Inflation Reports Will Determine Whether Rates Rise in September

by Team Lumida
1 day ago
Senate Confirms Kevin Warsh as Fed Chair in Closest Vote Ever

Kevin Warsh has built his Fed chairmanship on a promise to fight inflation without being handcuffed to monthly data — but the next two CPI reports will force...

Read more

Intel Raises $20 Billion in Upsized Share Sale — $100 Billion in Demand as AI Supply Chain Stocks Remain Investors’ Top Priority

by Team Lumida
1 day ago
a close up of a computer chip with the word intel core on it

Intel raised $20 billion in a share sale upsized by a third from its original $15 billion target, drawing more than $100 billion in investor demand and pricing...

Read more

AI-Dominated Leveraged ETFs Are Rattling Markets — 58% of Exposure Now Concentrated in a Handful of AI Names

by Team Lumida
1 day ago
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

A Bloomberg Big Take analysis finds that leveraged ETFs — which now account for a disproportionate share of daily equity trading despite modest total assets — have concentrated...

Read more
Next Post
white and black concrete building during night time

Paramount Wins Warner Discovery After Netflix Walks—A $81B Media Megamerger Takes Shape

Pentagon–Anthropic Feud Escalates as AI Policy Clash Threatens Defense Contracts

Anthropic Defies Pentagon on AI Guardrails, Raising Stakes for Defense Tech Policy

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Iran’s Island Fortress: The Five Strategic Positions Holding Hormuz Hostage

U.S. Pitches ‘Maritime Freedom Construct’ Coalition to Reopen the Strait of Hormuz

April 30, 2026
China’s Bold Economic Moves: What You Need to Know Now

Senior US-China Officials Commit to Keeping Communication Lines Open Amid Tensions

May 23, 2025
Tech Giants Plan to Skirt Trump’s $100,000 H-1B Fee

Tech Giants Plan to Skirt Trump’s $100,000 H-1B Fee

February 11, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018